NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: BASF

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

BASF Aroma Ingredients Expands its Isobionics® Portfolio with New Natural Flavors - Isobionics®, a BASF Aroma Ingredients brand, is launching a new natural product on the flavor market - BASF.com
BASF Aroma Ingredients Expands its Isobionics® Portfolio with New Natural Flavors

 

NewswireTODAY - /newswire/ - Geleen, Netherlands, 2024/03/12 - Isobionics®, a BASF Aroma Ingredients brand, is launching a new natural product on the flavor market - BASF.com. Frankfurt (BAS)

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

• Isobionics® Natural beta-Caryophyllene 80 is the latest addition to the Isobionics® flavor portfolio;
• Isobionics® Natural beta-Caryophyllene 80 is not derived from clove oil and has the benefit of no phenolic and no eugenol character; it is produced from renewable resources using cutting-edge biotechnology;
• New flavor was developed in response to specific customer requirements and will be presented at FlavourTalk Raw Materials Exhibition 2024.

Isobionics® Natural beta-Caryophyllene 80 is the latest addition to the Isobionics® portfolio, and is proof of the commitment to developing natural flavors driven by customer needs. Isobionics® Natural beta-Caryophyllene 80 will be presented for the first time at FlavourTalk Raw Materials Exhibition 2024, which will take place on March 20 at the Millennium Gloucester Hotel Conference Centre in London.

"We are delighted to introduce Isobionics® Natural beta-Caryophyllene 80 to the market; it’s a great addition to our portfolio of natural flavors. All our products are produced independent of the plant environment and harvest conditions and are pesticide-free," says Giovanni D’Andola, Flavor Launch Manager at BASF. "Building on our cutting-edge fermentation technology, we’re constantly expanding our natural flavor portfolio beyond our well-established citrus products to address further customer and market demands."

Breaking new ground beyond the citrus portfolio, Isobionics® is unlocking a world of new possibilities for food, beverage, and flavor enthusiasts by introducing the following new products:

• Isobionics® Natural beta-Caryophyllene 80 has an herbaceous, slightly green, parsley, black pepper, grapefruit, slightly clary sage odor. The taste at 10 to 20 ppm is woody, grapefruit, citrus, mango and pear skin.
• Isobionics® Natural beta-Caryophyllene 80 is not derived from clove oil and has the benefit of no phenolic and no eugenol character. This makes applications in citrus flavors like orange, grapefruit, black pepper, ylang-ylang and peppermint oils possible. With 80% purity, the product is suitable for a broad range of applications like beverages, food and fragrances. Our cutting-edge fermentation technology lets us guarantee premium quality and reliable availability.
• Isobionics® Natural beta-Caryophyllene 80 is compliant with EU and US food grade regulations, respectively FLAVIS: 01.007 and FEMA number 2252. The product is EU and US natural, pesticide-free1, kosher and halal certified.

Our new flavor expands the flavorist palette to a new level

This flavor ingredient produced at very high concentration using fermentation technology can be found not only in citrus essential oils, but also in several other natural oils, such as ylang-ylang, black pepper, clove, guava, thyme, rosemary, peppermint, eucalyptus, cinnamon, lavender and sage. This natural product uses only renewable raw materials, which makes it independent of harvest conditions and seasonality; it is also free of agricultural residues.

"Isobionics® Natural beta-Caryophyllene 80 is another proof point for our customer-centric innovation, meeting our customers demands for fermentation-based natural flavors. We are proud to offer the next innovative aroma ingredient that prioritizes quality and sustainability in the flavor industry," says Steffen Götz, Vice President of Aroma Ingredients at BASF.

The biotech platform plays a significant role in developing future ingredients to deliver exceptional flavor profiles that are geared to consumer preferences.

The new natural flavor Isobionics® Natural beta-Caryophyllene 80 has now been officially launched. Customers can already reach out to their designated sales contacts and schedule an exclusive presentation of the new flavor to experience this extraordinary flavor innovation firsthand.

1. Regular checks performed according to DIN-EN 15662. List of commodity/pesticide combination can be made available upon request.

About BASF’s Nutrition & Health division

BASF Nutrition & Health provides a comprehensive product and service range for human and animal nutrition, pharmaceutical, and flavor & fragrance industries. With our science-driven portfolio, we address customers in globally growing markets to meet the demands of an expanding world population. Together with our customers, we play an active role in enhancing the nutrition, health and wellbeing of consumers all over the world. Our products fulfill the highest safety, regulatory and sustainability standards. BASF Nutrition & Health operates sites in Europe, North America and in Asia-Pacific.

About BASF

At BASF (basf.com), we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. Around 112,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio comprises six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions. BASF generated sales of €68.9 billion in 2023. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the United States.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: BASF

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


BASF Aroma Ingredients Expands its Isobionics® Portfolio with New Natural Flavors

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Isobionics® | BASF’s Nutrition & Health
Contact: Nadja-Lea Walz - BASF.com 
+49 1520 9376883 nadja-lea.walz[.]basf.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any BASF securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From BASF / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

HUB Organoids B.V. Awarded Frost & Sullivan’s 2024 Technology Innovation Leadership Award for Transforming Drug Development
Immunology Consultants Laboratory Rebrand Highlights R&D and Service Specializations
Ipsen and Skyhawk Therapeutics Announce RNA Targeting Research Collaboration in Rare Neurological Diseases
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer At AACR 2024
Bruker Showcases High-Performance Solutions at Analytica 2024 for Research and Analysis in Applied, Industrial and Biopharma Laboratories
STEMCELL Technologies Announces FDA De Novo Classification for Its EasySep™ CD138 Positive Selection Kit to Support Cancer Diagnostic Tests
ONO Implements Oracle's CTMS for Global Centralized Management of Clinical Trials
Bruker Completes Acquisition of Optical Cell Imaging Company Phasefocus
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
SCHOTT Pharma Offers Complete Testing Suite for Container Selection and Drug Submission Preparation
STEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Biotechnologies Company
Ipsen’s Onivyde® Regimen, A Potential New Standard-of-care First-line Therapy in Metastatic Pancreatic Adenocarcinoma, Approved by FDA
Frost & Sullivan and Trautec have Conducted An Extensive Investigation Across the Recombinant Type XVII Collagen Industry Chain
Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050
Bushu Pharma Recognized with Frost & Sullivan’s 2023 Japan Customer Value Leadership Award for Offering Advanced Pharmaceutical Manufacturing

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  Limelon Advertising, Co.





 
  ©2005-2024 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)